Angiogenesis can also be increased in the presence of semaphorins, and receptors for semaphorin 3C, particularly plexin D1, are upregulated in the tumor vasculature making it a potential drug candidate (30, 62). The gene discussed is PLXND1; the disease is neoplasm.